Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
Manus Neurodynamica has raised €1.3M across 1 funding round, most recently a round in Jan 2021. Based in Edinburgh, UK; founded 2008; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-01-25 | Other | €1.3M |
| — |
| View deal → |
